secwatch.observer — SEC 8-K summary
======================================

Issuer:     T2 Biosystems, Inc. (—)
CIK:        0001492674
Form:       8-K
Filed at:   2024-05-14T23:59:59+00:00
Accession:  0001193125-24-138321
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 5.03
LLM model:  deepseek-v4-flash:cloud@v2

T2 Biosystems amendments enable CRG debt-to-equity conversion; CRG now owns 69%
-------------------------------------------------------------------------------

- Removed beneficial ownership limitations on Series A and B Preferred Stock on May 9, 2024.
- CRG converted all preferred shares into 1,824,800 common shares, raising its ownership to ~69%.
- This follows prior conversions of $15M (May 2024) and $10M (July 2023) debt from CRG into equity.
- As a result, CRG now holds a controlling stake, significantly diluting other shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1492674/000119312524138321/0001193125-24-138321-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1492674/000119312524138321/d836013d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-138321

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer